{"transactions":[{"id":4632344,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":34322,"kind":"person","name":"HAUGEN JANET BRUTSCHEA","position":1,"cik":"0001185136","reported_name":"HAUGEN JANET BRUTSCHEA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Unit","published_at":"2026-10-02T21:10:42.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":44,"price":370.76,"value":16313.44,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."}],"balance_after":350.87,"derivative":{"underlying":"Common Stock","underlying_shares":44},"source":{"system":"sec-edgar","filing":"0000105770-26-000112","document":"wk-form4_1790961039.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000112/wk-form4_1790961039.xml","form_type":"4"}},{"id":4618170,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-15T20:37:47.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":false,"shares":2524,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019."}],"balance_after":0,"derivative":{"exercise_price":89.64,"expiration_date":"2028-02-20","underlying":"Common Stock","underlying_shares":2524},"source":{"system":"sec-edgar","filing":"0000105770-26-000110","document":"wk-form4_1789504664.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000110/wk-form4_1789504664.xml","form_type":"4"}},{"id":4618169,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-15T20:37:47.000Z","date":"2026-09-14","kind":"exercise","planned":true,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019."}],"balance_after":2524,"derivative":{"exercise_price":89.64,"expiration_date":"2028-02-20","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000105770-26-000110","document":"wk-form4_1789504664.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000110/wk-form4_1789504664.xml","form_type":"4"}},{"id":4618168,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-15T20:37:47.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019."}],"balance_after":5024,"derivative":{"exercise_price":89.64,"expiration_date":"2028-02-20","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000105770-26-000110","document":"wk-form4_1789504664.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000110/wk-form4_1789504664.xml","form_type":"4"}},{"id":4618167,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-09-15T20:37:47.000Z","date":"2026-09-15","kind":"sale","planned":true,"acquired":false,"shares":2524,"price":365,"value":921260.0,"ownership":{"direct":true},"balance_after":21817.8098,"source":{"system":"sec-edgar","filing":"0000105770-26-000110","document":"wk-form4_1789504664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000110/wk-form4_1789504664.xml","form_type":"4"}},{"id":4618166,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-09-15T20:37:47.000Z","date":"2026-09-15","kind":"exercise","planned":true,"acquired":true,"shares":2524,"price":89.64,"value":226251.36,"ownership":{"direct":true},"balance_after":24341.8098,"source":{"system":"sec-edgar","filing":"0000105770-26-000110","document":"wk-form4_1789504664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000110/wk-form4_1789504664.xml","form_type":"4"}},{"id":4618165,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-09-15T20:37:47.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":355,"value":887500.0,"ownership":{"direct":true},"balance_after":21817.8098,"source":{"system":"sec-edgar","filing":"0000105770-26-000110","document":"wk-form4_1789504664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000110/wk-form4_1789504664.xml","form_type":"4"}},{"id":4618164,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-09-15T20:37:47.000Z","date":"2026-09-14","kind":"exercise","planned":true,"acquired":true,"shares":2500,"price":89.64,"value":224100.0,"ownership":{"direct":true},"balance_after":24317.8098,"source":{"system":"sec-edgar","filing":"0000105770-26-000110","document":"wk-form4_1789504664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000110/wk-form4_1789504664.xml","form_type":"4"}},{"id":4618163,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-09-15T20:37:47.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":2500,"price":345,"value":862500.0,"ownership":{"direct":true},"balance_after":21817.8098,"source":{"system":"sec-edgar","filing":"0000105770-26-000110","document":"wk-form4_1789504664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000110/wk-form4_1789504664.xml","form_type":"4"}},{"id":4618162,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-09-15T20:37:47.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":true,"shares":2500,"price":89.64,"value":224100.0,"ownership":{"direct":true},"balance_after":24317.8098,"source":{"system":"sec-edgar","filing":"0000105770-26-000110","document":"wk-form4_1789504664.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000110/wk-form4_1789504664.xml","form_type":"4"}},{"id":4615052,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-10T21:36:54.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award granted on February 20, 2018 vested in four equal annual installments beginning on February 20, 2019."}],"balance_after":7524,"derivative":{"exercise_price":89.64,"expiration_date":"2028-02-20","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0000105770-26-000108","document":"wk-form4_1789076210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000108/wk-form4_1789076210.xml","form_type":"4"}},{"id":4615051,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-09-10T21:36:54.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":false,"shares":2818,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award granted on February 21, 2017 vested in four equal annual installments beginning on February 21, 2018."}],"balance_after":0,"derivative":{"exercise_price":83.47,"expiration_date":"2027-02-21","underlying":"Common Stock","underlying_shares":2818},"source":{"system":"sec-edgar","filing":"0000105770-26-000108","document":"wk-form4_1789076210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000108/wk-form4_1789076210.xml","form_type":"4"}},{"id":4615050,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-09-10T21:36:54.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":false,"shares":2817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award granted on February 21, 2017 vested in four equal annual installments beginning on February 21, 2018."}],"balance_after":2818,"derivative":{"exercise_price":83.47,"expiration_date":"2027-02-21","underlying":"Common Stock","underlying_shares":2817},"source":{"system":"sec-edgar","filing":"0000105770-26-000108","document":"wk-form4_1789076210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000108/wk-form4_1789076210.xml","form_type":"4"}},{"id":4615049,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-09-10T21:36:54.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":2500,"price":340.81,"value":852025.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price resulting in such weighted average price."}],"balance_after":16844.5548,"source":{"system":"sec-edgar","filing":"0000105770-26-000108","document":"wk-form4_1789076210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000108/wk-form4_1789076210.xml","form_type":"4"}},{"id":4615048,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-09-10T21:36:54.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":89.64,"value":224100.0,"ownership":{"direct":true},"balance_after":19344.5548,"source":{"system":"sec-edgar","filing":"0000105770-26-000108","document":"wk-form4_1789076210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000108/wk-form4_1789076210.xml","form_type":"4"}},{"id":4615047,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-09-10T21:36:54.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":2818,"price":340.81,"value":960402.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price resulting in such weighted average price."}],"balance_after":16844.5548,"source":{"system":"sec-edgar","filing":"0000105770-26-000108","document":"wk-form4_1789076210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000108/wk-form4_1789076210.xml","form_type":"4"}},{"id":4615046,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-09-10T21:36:54.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":true,"shares":2818,"price":83.47,"value":235218.46,"ownership":{"direct":true},"balance_after":19662.5548,"source":{"system":"sec-edgar","filing":"0000105770-26-000108","document":"wk-form4_1789076210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000108/wk-form4_1789076210.xml","form_type":"4"}},{"id":4615045,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-09-10T21:36:54.000Z","date":"2026-09-08","kind":"sale","planned":false,"acquired":false,"shares":2817,"price":340.81,"value":960061.77,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price resulting in such weighted average price."}],"balance_after":16844.5548,"source":{"system":"sec-edgar","filing":"0000105770-26-000108","document":"wk-form4_1789076210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000108/wk-form4_1789076210.xml","form_type":"4"}},{"id":4615044,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-09-10T21:36:54.000Z","date":"2026-09-08","kind":"exercise","planned":false,"acquired":true,"shares":2817,"price":83.47,"value":235134.99,"ownership":{"direct":true},"balance_after":19661.5548,"source":{"system":"sec-edgar","filing":"0000105770-26-000108","document":"wk-form4_1789076210.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1654975/000010577026000108/wk-form4_1789076210.xml","form_type":"4"}},{"id":4614480,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":14719,"kind":"person","name":"Lagarde Michel","position":1,"cik":"0001518973","reported_name":"Lagarde Michel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Rst. Stock Unit","published_at":"2026-09-10T19:40:17.000Z","date":"2026-09-08","kind":"grant","planned":false,"acquired":true,"shares":3600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of WST common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award cliff vests on September 8, 2031."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award cliff vests on September 8, 2031."}],"balance_after":3600,"derivative":{"underlying":"Common Stock","underlying_shares":3600},"source":{"system":"sec-edgar","filing":"0001518973-26-000007","document":"wk-form4_1789069215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1518973/000151897326000007/wk-form4_1789069215.xml","form_type":"4"}},{"id":4614479,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":14719,"kind":"person","name":"Lagarde Michel","position":1,"cik":"0001518973","reported_name":"Lagarde Michel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Rst. Stock Unit","published_at":"2026-09-10T19:40:17.000Z","date":"2026-09-08","kind":"grant","planned":false,"acquired":true,"shares":4950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of WST common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in four equal annual installments beginning on September 8, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests in four equal annual installments beginning on September 8, 2027."}],"balance_after":4950,"derivative":{"underlying":"Common Stock","underlying_shares":4950},"source":{"system":"sec-edgar","filing":"0001518973-26-000007","document":"wk-form4_1789069215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1518973/000151897326000007/wk-form4_1789069215.xml","form_type":"4"}},{"id":4614478,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":14719,"kind":"person","name":"Lagarde Michel","position":1,"cik":"0001518973","reported_name":"Lagarde Michel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Rst. Stock Unit","published_at":"2026-09-10T19:40:17.000Z","date":"2026-09-08","kind":"grant","planned":false,"acquired":true,"shares":6200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of WST common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in four equal annual installments beginning on September 8, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests in four equal annual installments beginning on September 8, 2027."}],"balance_after":6200,"derivative":{"underlying":"Common Stock","underlying_shares":6200},"source":{"system":"sec-edgar","filing":"0001518973-26-000007","document":"wk-form4_1789069215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1518973/000151897326000007/wk-form4_1789069215.xml","form_type":"4"}},{"id":4614477,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":14719,"kind":"person","name":"Lagarde Michel","position":1,"cik":"0001518973","reported_name":"Lagarde Michel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-10T19:40:17.000Z","date":"2026-09-08","kind":"grant","planned":false,"acquired":true,"shares":12088,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award cliff vests on September 8, 2031."}],"balance_after":12088,"derivative":{"exercise_price":337.75,"expiration_date":"2036-09-08","underlying":"Common Stock","underlying_shares":12088},"source":{"system":"sec-edgar","filing":"0001518973-26-000007","document":"wk-form4_1789069215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1518973/000151897326000007/wk-form4_1789069215.xml","form_type":"4"}},{"id":4614476,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":14719,"kind":"person","name":"Lagarde Michel","position":1,"cik":"0001518973","reported_name":"Lagarde Michel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-10T19:40:17.000Z","date":"2026-09-08","kind":"grant","planned":false,"acquired":true,"shares":11081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in four equal annual installments beginning on September 8, 2027."}],"balance_after":11081,"derivative":{"exercise_price":337.75,"expiration_date":"2036-09-08","underlying":"Common Stock","underlying_shares":11081},"source":{"system":"sec-edgar","filing":"0001518973-26-000007","document":"wk-form4_1789069215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1518973/000151897326000007/wk-form4_1789069215.xml","form_type":"4"}},{"id":4614475,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":14719,"kind":"person","name":"Lagarde Michel","position":1,"cik":"0001518973","reported_name":"Lagarde Michel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-09-10T19:40:17.000Z","date":"2026-09-08","kind":"grant","planned":false,"acquired":true,"shares":13879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in four equal annual installments beginning on September 8, 2027."}],"balance_after":13879,"derivative":{"exercise_price":337.75,"expiration_date":"2036-09-08","underlying":"Common Stock","underlying_shares":13879},"source":{"system":"sec-edgar","filing":"0001518973-26-000007","document":"wk-form4_1789069215.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1518973/000151897326000007/wk-form4_1789069215.xml","form_type":"4"}},{"id":690033,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":24377,"kind":"person","name":"McMahon Robert W.","position":1,"cik":"0001608730","reported_name":"McMahon Robert W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Rst. Stock Unit","published_at":"2026-08-12T18:56:50.000Z","date":"2026-08-11","kind":"exercise","planned":false,"acquired":false,"shares":794.469,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of WST common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This award vests in four equal annual installments beginning on August 11, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"This award vests in four equal annual installments beginning on August 11, 2026."}],"balance_after":2383.4,"derivative":{"underlying":"Common Stock","underlying_shares":794.469},"source":{"system":"sec-edgar","filing":"0000105770-26-000104","document":"wk-form4_1786561008.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000104/wk-form4_1786561008.xml","form_type":"4"}},{"id":690032,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":24377,"kind":"person","name":"McMahon Robert W.","position":1,"cik":"0001608730","reported_name":"McMahon Robert W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Rst. Stock Unit","published_at":"2026-08-12T18:56:50.000Z","date":"2026-08-11","kind":"exercise","planned":false,"acquired":false,"shares":6354.736,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of WST common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 11, 2025, the reporting person was granted 12,670 restricted stock units, vesting in three installments - 4,223 shares (plus dividend equivalents) to vest six months from the grant date, 6,335 shares (plus dividend equivalents) to vest 12 months from the grant date and 2,112 shares (plus dividend equivalents) to vest 24 months from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 11, 2025, the reporting person was granted 12,670 restricted stock units, vesting in three installments - 4,223 shares (plus dividend equivalents) to vest six months from the grant date, 6,335 shares (plus dividend equivalents) to vest 12 months from the grant date and 2,112 shares (plus dividend equivalents) to vest 24 months from the grant date."}],"balance_after":2118.579,"derivative":{"underlying":"Common Stock","underlying_shares":6354.736},"source":{"system":"sec-edgar","filing":"0000105770-26-000104","document":"wk-form4_1786561008.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000104/wk-form4_1786561008.xml","form_type":"4"}},{"id":690031,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":24377,"kind":"person","name":"McMahon Robert W.","position":1,"cik":"0001608730","reported_name":"McMahon Robert W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-12T18:56:50.000Z","date":"2026-08-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":2763.675,"price":351.37,"value":971072.48475,"ownership":{"direct":true},"balance_after":7020.506,"source":{"system":"sec-edgar","filing":"0000105770-26-000104","document":"wk-form4_1786561008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000104/wk-form4_1786561008.xml","form_type":"4"}},{"id":690030,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":24377,"kind":"person","name":"McMahon Robert W.","position":1,"cik":"0001608730","reported_name":"McMahon Robert W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-12T18:56:50.000Z","date":"2026-08-11","kind":"exercise","planned":false,"acquired":true,"shares":6354.736,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of WST common stock."}],"balance_after":9784.181,"source":{"system":"sec-edgar","filing":"0000105770-26-000104","document":"wk-form4_1786561008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000104/wk-form4_1786561008.xml","form_type":"4"}},{"id":690029,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":24377,"kind":"person","name":"McMahon Robert W.","position":1,"cik":"0001608730","reported_name":"McMahon Robert W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-12T18:56:50.000Z","date":"2026-08-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":345.515,"price":351.37,"value":121403.60555,"ownership":{"direct":true},"balance_after":3429.445,"source":{"system":"sec-edgar","filing":"0000105770-26-000104","document":"wk-form4_1786561008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000104/wk-form4_1786561008.xml","form_type":"4"}},{"id":690028,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":24377,"kind":"person","name":"McMahon Robert W.","position":1,"cik":"0001608730","reported_name":"McMahon Robert W.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-12T18:56:50.000Z","date":"2026-08-11","kind":"exercise","planned":false,"acquired":true,"shares":794.469,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of WST common stock."}],"balance_after":3774.96,"source":{"system":"sec-edgar","filing":"0000105770-26-000104","document":"wk-form4_1786561008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000104/wk-form4_1786561008.xml","form_type":"4"}},{"id":722306,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":34322,"kind":"person","name":"HAUGEN JANET BRUTSCHEA","position":1,"cik":"0001185136","reported_name":"HAUGEN JANET BRUTSCHEA","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Stock Unit","published_at":"2026-07-01T23:06:28.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":46,"price":359,"value":16514.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."}],"balance_after":306.678,"derivative":{"underlying":"Common Stock","underlying_shares":46},"source":{"system":"sec-edgar","filing":"0000105770-26-000085","document":"wk-form4_1782947185.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000085/wk-form4_1782947185.xml","form_type":"4"}},{"id":780094,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Rst. Stock Unit","published_at":"2026-05-14T20:00:32.000Z","date":"2026-05-12","kind":"exercise","planned":false,"acquired":false,"shares":473.593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 12, 2025, the reporting person was granted 1,891 restricted stock units, vesting in four equal annual installments (plus dividend equivalents)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 12, 2025, the reporting person was granted 1,891 restricted stock units, vesting in four equal annual installments (plus dividend equivalents)."}],"balance_after":1417.407,"derivative":{"underlying":"Common Stock","underlying_shares":473.593},"source":{"system":"sec-edgar","filing":"0000105770-26-000075","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000075/form4.xml","form_type":"4"}},{"id":780093,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Rst. Stock Unit","published_at":"2026-05-14T20:00:32.000Z","date":"2026-05-12","kind":"exercise","planned":false,"acquired":false,"shares":295.995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 12, 2025, the reporting person was granted 1,182 restricted stock units, vesting in four equal annual installments (plus dividend equivalents)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 12, 2025, the reporting person was granted 1,182 restricted stock units, vesting in four equal annual installments (plus dividend equivalents)."}],"balance_after":886.005,"derivative":{"underlying":"Common Stock","underlying_shares":295.995},"source":{"system":"sec-edgar","filing":"0000105770-26-000075","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000075/form4.xml","form_type":"4"}},{"id":780092,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Common Stock","published_at":"2026-05-14T20:00:32.000Z","date":"2026-05-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":134.927,"price":312.07,"value":42106.66889,"ownership":{"direct":true},"balance_after":612.7964,"source":{"system":"sec-edgar","filing":"0000105770-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000075/form4.xml","form_type":"4"}},{"id":780091,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Common Stock","published_at":"2026-05-14T20:00:32.000Z","date":"2026-05-12","kind":"exercise","planned":false,"acquired":true,"shares":473.593,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":747.7234,"source":{"system":"sec-edgar","filing":"0000105770-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000075/form4.xml","form_type":"4"}},{"id":780090,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Common Stock","published_at":"2026-05-14T20:00:32.000Z","date":"2026-05-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":84.329,"price":312.07,"value":26316.55103,"ownership":{"direct":true},"balance_after":274.1304,"source":{"system":"sec-edgar","filing":"0000105770-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000075/form4.xml","form_type":"4"}},{"id":780089,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Common Stock","published_at":"2026-05-14T20:00:32.000Z","date":"2026-05-12","kind":"exercise","planned":false,"acquired":true,"shares":295.995,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":358.4594,"source":{"system":"sec-edgar","filing":"0000105770-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000075/form4.xml","form_type":"4"}},{"id":790776,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":49537,"kind":"person","name":"Pucci Paolo","position":1,"cik":"0001436861","reported_name":"Pucci Paolo","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-06T21:37:23.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors."}],"balance_after":11854.297,"source":{"system":"sec-edgar","filing":"0000105770-26-000066","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000066/form4.xml","form_type":"4"}},{"id":790775,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":49536,"kind":"person","name":"Michels Douglas A","position":1,"cik":"0001295391","reported_name":"Michels Douglas A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-06T21:35:24.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors."}],"balance_after":46495.55,"source":{"system":"sec-edgar","filing":"0000105770-26-000065","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000065/form4.xml","form_type":"4"}},{"id":790774,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":33073,"kind":"person","name":"Lockhart Stephen H","position":1,"cik":"0001856013","reported_name":"Lockhart Stephen H","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-06T21:33:50.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting."}],"balance_after":3523.2615,"source":{"system":"sec-edgar","filing":"0000105770-26-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000064/form4.xml","form_type":"4"}},{"id":790773,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":31274,"kind":"person","name":"LAI GOLDMAN MYLA","position":1,"cik":"0001168581","reported_name":"LAI GOLDMAN MYLA","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-06T21:32:27.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors."}],"balance_after":20434.587,"source":{"system":"sec-edgar","filing":"0000105770-26-000063","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000063/form4.xml","form_type":"4"}},{"id":790772,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":49535,"kind":"person","name":"Keller Deborah L","position":1,"cik":"0001352992","reported_name":"Keller Deborah L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-06T21:30:39.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting."}],"balance_after":11560.479,"source":{"system":"sec-edgar","filing":"0000105770-26-000062","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000062/form4.xml","form_type":"4"}},{"id":790771,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":38746,"kind":"person","name":"Joseph Molly","position":1,"cik":"0001709261","reported_name":"Joseph Molly","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-06T21:29:06.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting."}],"balance_after":4398.187,"source":{"system":"sec-edgar","filing":"0000105770-26-000061","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000061/form4.xml","form_type":"4"}},{"id":790769,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":34322,"kind":"person","name":"HAUGEN JANET BRUTSCHEA","position":1,"cik":"0001185136","reported_name":"HAUGEN JANET BRUTSCHEA","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-06T21:26:50.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors."}],"balance_after":2372.752,"source":{"system":"sec-edgar","filing":"0000105770-26-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000060/form4.xml","form_type":"4"}},{"id":790770,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":46856,"kind":"person","name":"FRIEL ROBERT F","position":1,"cik":"0001224110","reported_name":"FRIEL ROBERT F","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-06T21:23:31.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors."}],"balance_after":5512.97,"source":{"system":"sec-edgar","filing":"0000105770-26-000059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000059/form4.xml","form_type":"4"}},{"id":790768,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":49534,"kind":"person","name":"Feehery William F","position":1,"cik":"0001543193","reported_name":"Feehery William F","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-06T21:21:35.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting and will be distributable under the terms of the Deferred Compensation Plan for Outside Directors."}],"balance_after":32519.345,"source":{"system":"sec-edgar","filing":"0000105770-26-000058","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000058/form4.xml","form_type":"4"}},{"id":790767,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":48925,"kind":"person","name":"BUTHMAN MARK A","position":1,"cik":"0001223783","reported_name":"BUTHMAN MARK A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-06T21:18:13.000Z","date":"2026-05-04","kind":"grant","planned":false,"acquired":true,"shares":791,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting."}],"balance_after":44308.5494,"source":{"system":"sec-edgar","filing":"0000105770-26-000057","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000057/form4.xml","form_type":"4"}},{"id":798319,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"officer":true,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-04-29T16:22:22.000Z","date":"2026-04-27","kind":"exercise","planned":false,"acquired":false,"shares":2817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award granted on February 21, 2017 vested in four equal annual installments beginning on February 21, 2018."}],"balance_after":5635,"derivative":{"exercise_price":83.47,"exercise_date":"2018-02-21","expiration_date":"2027-02-21","underlying":"Common Stock","underlying_shares":2817},"source":{"system":"sec-edgar","filing":"0000105770-26-000054","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000054/form4.xml","form_type":"4"}},{"id":798318,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"officer":true,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-04-29T16:22:22.000Z","date":"2026-04-27","kind":"sale","planned":false,"acquired":false,"shares":2817,"price":305.2018,"value":859753.4706,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price."}],"balance_after":16828.4906,"source":{"system":"sec-edgar","filing":"0000105770-26-000054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000054/form4.xml","form_type":"4"}},{"id":798317,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"officer":true,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-04-29T16:22:22.000Z","date":"2026-04-27","kind":"exercise","planned":false,"acquired":true,"shares":2817,"price":83.47,"value":235134.99,"ownership":{"direct":true},"balance_after":19645.4906,"source":{"system":"sec-edgar","filing":"0000105770-26-000054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000054/form4.xml","form_type":"4"}},{"id":798316,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50936,"kind":"person","name":"Winters Chad","position":1,"cik":"0001811424","reported_name":"Winters Chad","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-04-29T16:19:44.000Z","date":"2026-04-27","kind":"exercise","planned":false,"acquired":false,"shares":896,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award granted on February 18, 2020 vested in four equal annual installments beginning on February 18, 2021."}],"balance_after":0,"derivative":{"exercise_price":173.22,"exercise_date":"2021-02-18","expiration_date":"2030-02-18","underlying":"Common Stock","underlying_shares":896},"source":{"system":"sec-edgar","filing":"0000105770-26-000053","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000053/form4.xml","form_type":"4"}},{"id":798315,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50936,"kind":"person","name":"Winters Chad","position":1,"cik":"0001811424","reported_name":"Winters Chad","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-04-29T16:19:44.000Z","date":"2026-04-27","kind":"sale","planned":false,"acquired":false,"shares":896,"price":300.6688,"value":269399.2448,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price."}],"balance_after":1522.81,"source":{"system":"sec-edgar","filing":"0000105770-26-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000053/form4.xml","form_type":"4"}},{"id":798314,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50936,"kind":"person","name":"Winters Chad","position":1,"cik":"0001811424","reported_name":"Winters Chad","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-04-29T16:19:44.000Z","date":"2026-04-27","kind":"exercise","planned":false,"acquired":true,"shares":896,"price":173.22,"value":155205.12,"ownership":{"direct":true},"balance_after":2418.81,"source":{"system":"sec-edgar","filing":"0000105770-26-000053","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000053/form4.xml","form_type":"4"}},{"id":823695,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":34322,"kind":"person","name":"HAUGEN JANET BRUTSCHEA","position":1,"cik":"0001185136","reported_name":"HAUGEN JANET BRUTSCHEA","relationship":{"director":true}}],"security":"Phantom Stock Unit","published_at":"2026-04-01T18:17:56.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":52,"price":250.64,"value":13033.28,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."}],"balance_after":260.494,"derivative":{"underlying":"Common Stock","underlying_shares":52},"source":{"system":"sec-edgar","filing":"0000105770-26-000043","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000043/form4.xml","form_type":"4"}},{"id":872209,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":63769,"kind":"person","name":"Finch Norman D. Jr.","position":1,"cik":"0001577064","reported_name":"Finch Norman D. Jr.","relationship":{"officer":true,"officer_title":"SVP, GC & Corporate Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T16:36:07.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":3057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in four equal annual installments beginning on March 1, 2027."}],"balance_after":3057,"derivative":{"exercise_price":254.34,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":3057},"source":{"system":"sec-edgar","filing":"0000105770-26-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000039/form4.xml","form_type":"4"}},{"id":872208,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":63769,"kind":"person","name":"Finch Norman D. Jr.","position":1,"cik":"0001577064","reported_name":"Finch Norman D. Jr.","relationship":{"officer":true,"officer_title":"SVP, GC & Corporate Secretary"}}],"security":"Rst. Stock Unit","published_at":"2026-03-03T16:36:07.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":1285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of WST common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."}],"balance_after":1285,"derivative":{"underlying":"Common Stock","underlying_shares":1285},"source":{"system":"sec-edgar","filing":"0000105770-26-000039","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000039/form4.xml","form_type":"4"}},{"id":872207,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":33661,"kind":"person","name":"Green Eric Mark","position":1,"cik":"0001336007","reported_name":"Green Eric Mark","relationship":{"director":true,"officer":true,"officer_title":"President, CEO and Board Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T16:33:02.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":16630,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in four equal annual installments beginning on March 1, 2027."}],"balance_after":16630,"derivative":{"exercise_price":254.34,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":16630},"source":{"system":"sec-edgar","filing":"0000105770-26-000038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000038/form4.xml","form_type":"4"}},{"id":872206,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":33661,"kind":"person","name":"Green Eric Mark","position":1,"cik":"0001336007","reported_name":"Green Eric Mark","relationship":{"director":true,"officer":true,"officer_title":"President, CEO and Board Chair"}}],"security":"Rst. Stock Unit","published_at":"2026-03-03T16:33:02.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":6986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of WST common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."}],"balance_after":6986,"derivative":{"underlying":"Common Stock","underlying_shares":6986},"source":{"system":"sec-edgar","filing":"0000105770-26-000038","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000038/form4.xml","form_type":"4"}},{"id":872205,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"officer":true,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T16:30:55.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":1712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in four equal annual installments beginning on March 1, 2027."}],"balance_after":1712,"derivative":{"exercise_price":254.34,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":1712},"source":{"system":"sec-edgar","filing":"0000105770-26-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000037/form4.xml","form_type":"4"}},{"id":872204,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"officer":true,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Rst. Stock Unit","published_at":"2026-03-03T16:30:55.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of WST common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."}],"balance_after":720,"derivative":{"underlying":"Common Stock","underlying_shares":720},"source":{"system":"sec-edgar","filing":"0000105770-26-000037","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000037/form4.xml","form_type":"4"}},{"id":872203,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T16:28:56.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":2691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in four equal annual installments beginning on March 1, 2027."}],"balance_after":2691,"derivative":{"exercise_price":254.34,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":2691},"source":{"system":"sec-edgar","filing":"0000105770-26-000036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000036/form4.xml","form_type":"4"}},{"id":872202,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Rst. Stock Unit","published_at":"2026-03-03T16:28:56.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":1131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of WST common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."}],"balance_after":1131,"derivative":{"underlying":"Common Stock","underlying_shares":1131},"source":{"system":"sec-edgar","filing":"0000105770-26-000036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000036/form4.xml","form_type":"4"}},{"id":872201,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":24377,"kind":"person","name":"McMahon Robert W.","position":1,"cik":"0001608730","reported_name":"McMahon Robert W.","relationship":{"officer":true,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T16:26:41.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":7337,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in four equal annual installments beginning on March 1, 2027."}],"balance_after":7337,"derivative":{"exercise_price":254.34,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":7337},"source":{"system":"sec-edgar","filing":"0000105770-26-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000035/form4.xml","form_type":"4"}},{"id":872200,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":24377,"kind":"person","name":"McMahon Robert W.","position":1,"cik":"0001608730","reported_name":"McMahon Robert W.","relationship":{"officer":true,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Rst. Stock Unit","published_at":"2026-03-03T16:26:41.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":3082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of WST common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."}],"balance_after":3082,"derivative":{"underlying":"Common Stock","underlying_shares":3082},"source":{"system":"sec-edgar","filing":"0000105770-26-000035","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000035/form4.xml","form_type":"4"}},{"id":872199,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":63768,"kind":"person","name":"Poussot Rodolphe Jean","position":1,"cik":"0002079538","reported_name":"Poussot Rodolphe Jean","relationship":{"officer":true,"officer_title":"SVP, Strategy & Corporate Dev"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T16:24:00.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":1040,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in four equal annual installments beginning on March 1, 2027."}],"balance_after":1040,"derivative":{"exercise_price":254.34,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":1040},"source":{"system":"sec-edgar","filing":"0000105770-26-000034","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000034/form4.xml","form_type":"4"}},{"id":872198,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":63768,"kind":"person","name":"Poussot Rodolphe Jean","position":1,"cik":"0002079538","reported_name":"Poussot Rodolphe Jean","relationship":{"officer":true,"officer_title":"SVP, Strategy & Corporate Dev"}}],"security":"Rst. Stock Unit","published_at":"2026-03-03T16:24:00.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":437,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of WST common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."}],"balance_after":437,"derivative":{"underlying":"Common Stock","underlying_shares":437},"source":{"system":"sec-edgar","filing":"0000105770-26-000034","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000034/form4.xml","form_type":"4"}},{"id":872197,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50936,"kind":"person","name":"Winters Chad","position":1,"cik":"0001811424","reported_name":"Winters Chad","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T16:22:12.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":808,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in four equal annual installments beginning on March 1, 2027."}],"balance_after":808,"derivative":{"exercise_price":254.34,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":808},"source":{"system":"sec-edgar","filing":"0000105770-26-000033","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000033/form4.xml","form_type":"4"}},{"id":872196,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50936,"kind":"person","name":"Winters Chad","position":1,"cik":"0001811424","reported_name":"Winters Chad","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Rst. Stock Unit","published_at":"2026-03-03T16:22:12.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of WST common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."}],"balance_after":340,"derivative":{"underlying":"Common Stock","underlying_shares":340},"source":{"system":"sec-edgar","filing":"0000105770-26-000033","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000033/form4.xml","form_type":"4"}},{"id":889664,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":63768,"kind":"person","name":"Poussot Rodolphe Jean","position":1,"cik":"0002079538","reported_name":"Poussot Rodolphe Jean","relationship":{"officer":true,"officer_title":"SVP, Strategy & Corporate Dev"}}],"security":"Rst. Stock Unit","published_at":"2026-02-23T22:44:10.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":false,"shares":383.382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 20, 2024, the reporting person was granted 1,143 restricted stock units, vesting in three equal annual installments (plus dividend equivalents)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 20, 2024, the reporting person was granted 1,143 restricted stock units, vesting in three equal annual installments (plus dividend equivalents)."}],"balance_after":383.359,"derivative":{"underlying":"Common Stock","underlying_shares":383.382},"source":{"system":"sec-edgar","filing":"0000105770-26-000025","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000025/form4.xml","form_type":"4"}},{"id":889663,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":63768,"kind":"person","name":"Poussot Rodolphe Jean","position":1,"cik":"0002079538","reported_name":"Poussot Rodolphe Jean","relationship":{"officer":true,"officer_title":"SVP, Strategy & Corporate Dev"}}],"security":"Common Stock","published_at":"2026-02-23T22:44:10.000Z","date":"2026-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":129.545,"price":241.12,"value":31235.8904,"ownership":{"direct":true},"balance_after":561.235,"source":{"system":"sec-edgar","filing":"0000105770-26-000025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000025/form4.xml","form_type":"4"}},{"id":889662,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":63768,"kind":"person","name":"Poussot Rodolphe Jean","position":1,"cik":"0002079538","reported_name":"Poussot Rodolphe Jean","relationship":{"officer":true,"officer_title":"SVP, Strategy & Corporate Dev"}}],"security":"Common Stock","published_at":"2026-02-23T22:44:10.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":true,"shares":383.382,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":690.78,"source":{"system":"sec-edgar","filing":"0000105770-26-000025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000025/form4.xml","form_type":"4"}},{"id":889661,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":65308,"kind":"person","name":"Witherspoon Charles","position":1,"cik":"0001731739","reported_name":"Witherspoon Charles","relationship":{"officer":true,"officer_title":"VP & Treasurer"}}],"security":"Rst. Stock Unit","published_at":"2026-02-23T22:41:39.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":false,"shares":60.22,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 18, 2025, the reporting person was granted 237 restricted stock units, vesting in four equal annual installments (plus dividend equivalents) on February 20th each year."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 18, 2025, the reporting person was granted 237 restricted stock units, vesting in four equal annual installments (plus dividend equivalents) on February 20th each year."}],"balance_after":177.644,"derivative":{"underlying":"Common Stock","underlying_shares":60.22},"source":{"system":"sec-edgar","filing":"0000105770-26-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000024/form4.xml","form_type":"4"}},{"id":889660,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":65308,"kind":"person","name":"Witherspoon Charles","position":1,"cik":"0001731739","reported_name":"Witherspoon Charles","relationship":{"officer":true,"officer_title":"VP & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-23T22:41:39.000Z","date":"2026-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":22.069,"price":241.12,"value":5321.27728,"ownership":{"direct":true},"balance_after":1407.897,"source":{"system":"sec-edgar","filing":"0000105770-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000024/form4.xml","form_type":"4"}},{"id":889659,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":65308,"kind":"person","name":"Witherspoon Charles","position":1,"cik":"0001731739","reported_name":"Witherspoon Charles","relationship":{"officer":true,"officer_title":"VP & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-23T22:41:39.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":true,"shares":60.22,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":1429.966,"source":{"system":"sec-edgar","filing":"0000105770-26-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000024/form4.xml","form_type":"4"}},{"id":889658,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50936,"kind":"person","name":"Winters Chad","position":1,"cik":"0001811424","reported_name":"Winters Chad","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Rst. Stock Unit","published_at":"2026-02-23T22:40:19.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":false,"shares":89.328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 18, 2025, the reporting person was granted 356 restricted stock units, vesting in four equal annual installments (plus dividend equivalents) on February 20th each year."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 18, 2025, the reporting person was granted 356 restricted stock units, vesting in four equal annual installments (plus dividend equivalents) on February 20th each year."}],"balance_after":267.972,"derivative":{"underlying":"Common Stock","underlying_shares":89.328},"source":{"system":"sec-edgar","filing":"0000105770-26-000023","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000023/form4.xml","form_type":"4"}},{"id":889657,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50936,"kind":"person","name":"Winters Chad","position":1,"cik":"0001811424","reported_name":"Winters Chad","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-23T22:40:19.000Z","date":"2026-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":30.184,"price":241.12,"value":7277.96608,"ownership":{"direct":true},"balance_after":1522.81,"source":{"system":"sec-edgar","filing":"0000105770-26-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000023/form4.xml","form_type":"4"}},{"id":889656,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50936,"kind":"person","name":"Winters Chad","position":1,"cik":"0001811424","reported_name":"Winters Chad","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-23T22:40:19.000Z","date":"2026-02-20","kind":"exercise","planned":false,"acquired":true,"shares":89.328,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":1552.994,"source":{"system":"sec-edgar","filing":"0000105770-26-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000023/form4.xml","form_type":"4"}},{"id":895122,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":63768,"kind":"person","name":"Poussot Rodolphe Jean","position":1,"cik":"0002079538","reported_name":"Poussot Rodolphe Jean","relationship":{"officer":true,"officer_title":"SVP, Strategy & Corporate Dev"}}],"security":"Rst. Stock Unit","published_at":"2026-02-20T00:05:52.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":false,"shares":82.299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 18, 2025, the reporting person was granted 329 restricted stock units, vesting in four equal annual installments (plus dividend equivalents)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 18, 2025, the reporting person was granted 329 restricted stock units, vesting in four equal annual installments (plus dividend equivalents)."}],"balance_after":247.899,"derivative":{"underlying":"Common Stock","underlying_shares":82.299},"source":{"system":"sec-edgar","filing":"0000105770-26-000020","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000020/form4.xml","form_type":"4"}},{"id":895121,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":63768,"kind":"person","name":"Poussot Rodolphe Jean","position":1,"cik":"0002079538","reported_name":"Poussot Rodolphe Jean","relationship":{"officer":true,"officer_title":"SVP, Strategy & Corporate Dev"}}],"security":"Common Stock","published_at":"2026-02-20T00:05:52.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":27.809,"price":248.26,"value":6903.86234,"ownership":{"direct":true},"balance_after":307.398,"source":{"system":"sec-edgar","filing":"0000105770-26-000020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000020/form4.xml","form_type":"4"}},{"id":895120,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":63768,"kind":"person","name":"Poussot Rodolphe Jean","position":1,"cik":"0002079538","reported_name":"Poussot Rodolphe Jean","relationship":{"officer":true,"officer_title":"SVP, Strategy & Corporate Dev"}}],"security":"Common Stock","published_at":"2026-02-20T00:05:52.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":82.299,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":335.207,"source":{"system":"sec-edgar","filing":"0000105770-26-000020","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000020/form4.xml","form_type":"4"}},{"id":895124,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":65308,"kind":"person","name":"Witherspoon Charles","position":1,"cik":"0001731739","reported_name":"Witherspoon Charles","relationship":{"officer":true,"officer_title":"VP & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-20T00:04:04.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":41.519,"price":243.19,"value":10097.00561,"ownership":{"direct":true},"balance_after":1369.746,"source":{"system":"sec-edgar","filing":"0000105770-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000019/form4.xml","form_type":"4"}},{"id":895123,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":65308,"kind":"person","name":"Witherspoon Charles","position":1,"cik":"0001731739","reported_name":"Witherspoon Charles","relationship":{"officer":true,"officer_title":"VP & Treasurer"}}],"security":"Common Stock","published_at":"2026-02-20T00:04:04.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":115.91,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares result from performance stock units (PSUs) which vested at the end of the respective 2023-2025 PSU performance period and were payable on the transaction date shown."}],"balance_after":1411.265,"source":{"system":"sec-edgar","filing":"0000105770-26-000019","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000019/form4.xml","form_type":"4"}},{"id":895119,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50936,"kind":"person","name":"Winters Chad","position":1,"cik":"0001811424","reported_name":"Winters Chad","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-20T00:02:29.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":50.579,"price":243.19,"value":12300.30701,"ownership":{"direct":true},"balance_after":1462.103,"source":{"system":"sec-edgar","filing":"0000105770-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000018/form4.xml","form_type":"4"}},{"id":895118,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50936,"kind":"person","name":"Winters Chad","position":1,"cik":"0001811424","reported_name":"Winters Chad","relationship":{"officer":true,"officer_title":"VP, Chief Accounting Officer"}}],"security":"Common Stock","published_at":"2026-02-20T00:02:29.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":149.684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares result from performance stock units (PSUs) which vested at the end of the respective 2023-2025 PSU performance period and were payable on the transaction date shown."}],"balance_after":1512.682,"source":{"system":"sec-edgar","filing":"0000105770-26-000018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000018/form4.xml","form_type":"4"}},{"id":895144,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":33661,"kind":"person","name":"Green Eric Mark","position":1,"cik":"0001336007","reported_name":"Green Eric Mark","relationship":{"director":true,"officer":true,"officer_title":"President, CEO and Board Chair"}}],"security":"Rst. Stock Unit","published_at":"2026-02-20T00:00:34.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":false,"shares":1318.81,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 18, 2025, the reporting person was granted 5,256 restricted stock units, vesting in four equal annual installments (plus dividend equivalents)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 18, 2025, the reporting person was granted 5,256 restricted stock units, vesting in four equal annual installments (plus dividend equivalents)."}],"balance_after":3956.409,"derivative":{"underlying":"Common Stock","underlying_shares":1318.81},"source":{"system":"sec-edgar","filing":"0000105770-26-000017","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000017/form4.xml","form_type":"4"}},{"id":895143,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":33661,"kind":"person","name":"Green Eric Mark","position":1,"cik":"0001336007","reported_name":"Green Eric Mark","relationship":{"director":true,"officer":true,"officer_title":"President, CEO and Board Chair"}}],"security":"Common Stock","published_at":"2026-02-20T00:00:34.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":573.551,"price":248.26,"value":142389.77126,"ownership":{"direct":true},"balance_after":175160.6588,"source":{"system":"sec-edgar","filing":"0000105770-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000017/form4.xml","form_type":"4"}},{"id":895142,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":33661,"kind":"person","name":"Green Eric Mark","position":1,"cik":"0001336007","reported_name":"Green Eric Mark","relationship":{"director":true,"officer":true,"officer_title":"President, CEO and Board Chair"}}],"security":"Common Stock","published_at":"2026-02-20T00:00:34.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":1318.81,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":175734.2098,"source":{"system":"sec-edgar","filing":"0000105770-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000017/form4.xml","form_type":"4"}},{"id":895141,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":33661,"kind":"person","name":"Green Eric Mark","position":1,"cik":"0001336007","reported_name":"Green Eric Mark","relationship":{"director":true,"officer":true,"officer_title":"President, CEO and Board Chair"}}],"security":"Common Stock","published_at":"2026-02-20T00:00:34.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1305.382,"price":243.19,"value":317455.84858,"ownership":{"direct":true},"balance_after":172894.6085,"source":{"system":"sec-edgar","filing":"0000105770-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000017/form4.xml","form_type":"4"}},{"id":895140,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":33661,"kind":"person","name":"Green Eric Mark","position":1,"cik":"0001336007","reported_name":"Green Eric Mark","relationship":{"director":true,"officer":true,"officer_title":"President, CEO and Board Chair"}}],"security":"Common Stock","published_at":"2026-02-20T00:00:34.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":4418.771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares result from performance stock units (PSUs) which vested at the end of the respective 2023-2025 PSU performance period and were payable on the transaction date shown."}],"balance_after":174199.9905,"source":{"system":"sec-edgar","filing":"0000105770-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000017/form4.xml","form_type":"4"}},{"id":895117,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"officer":true,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Rst. Stock Unit","published_at":"2026-02-19T23:58:47.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":false,"shares":135.491,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 18, 2025, the reporting person was granted 542 restricted stock units, vesting in four equal annual installments (plus dividend equivalents)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 18, 2025, the reporting person was granted 542 restricted stock units, vesting in four equal annual installments (plus dividend equivalents)."}],"balance_after":408.486,"derivative":{"underlying":"Common Stock","underlying_shares":135.491},"source":{"system":"sec-edgar","filing":"0000105770-26-000016","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000016/form4.xml","form_type":"4"}},{"id":895116,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"officer":true,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-02-19T23:58:47.000Z","date":"2026-02-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":35.757,"price":248.26,"value":8877.03282,"ownership":{"direct":true},"balance_after":17374.4904,"source":{"system":"sec-edgar","filing":"0000105770-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000016/form4.xml","form_type":"4"}},{"id":895115,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"officer":true,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-02-19T23:58:47.000Z","date":"2026-02-18","kind":"exercise","planned":false,"acquired":true,"shares":135.491,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":17410.2474,"source":{"system":"sec-edgar","filing":"0000105770-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000016/form4.xml","form_type":"4"}},{"id":895114,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"officer":true,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-02-19T23:58:47.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":150.443,"price":243.19,"value":36586.23317,"ownership":{"direct":true},"balance_after":17274.7564,"source":{"system":"sec-edgar","filing":"0000105770-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000016/form4.xml","form_type":"4"}},{"id":895113,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":50937,"kind":"person","name":"Favorite Annette F","position":1,"cik":"0001654975","reported_name":"Favorite Annette F","relationship":{"officer":true,"officer_title":"Sr. VP & Chief HR Officer"}}],"security":"Common Stock","published_at":"2026-02-19T23:58:47.000Z","date":"2026-02-17","kind":"grant","planned":false,"acquired":true,"shares":441.957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares result from performance stock units (PSUs) which vested at the end of the respective 2023-2025 PSU performance period and were payable on the transaction date shown."}],"balance_after":17425.1994,"source":{"system":"sec-edgar","filing":"0000105770-26-000016","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000016/form4.xml","form_type":"4"}},{"id":908908,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":24377,"kind":"person","name":"McMahon Robert W.","position":1,"cik":"0001608730","reported_name":"McMahon Robert W.","relationship":{"officer":true,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Rst. Stock Unit","published_at":"2026-02-13T02:37:44.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":false,"shares":4230.525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 11, 2025, the reporting person was granted 12,670 restricted stock units, vesting in three installments - 4,223 shares (plus dividend equivalents) to vest six months from the grant date, 6,335 shares (plus dividend equivalents) to vest 12 months from the grant date and 2,112 shares (plus dividend equivalents) to vest 24 months from the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 11, 2025, the reporting person was granted 12,670 restricted stock units, vesting in three installments - 4,223 shares (plus dividend equivalents) to vest six months from the grant date, 6,335 shares (plus dividend equivalents) to vest 12 months from the grant date and 2,112 shares (plus dividend equivalents) to vest 24 months from the grant date."}],"balance_after":8462.052,"derivative":{"underlying":"Common Stock","underlying_shares":4230.525},"source":{"system":"sec-edgar","filing":"0000105770-26-000007","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000007/form4.xml","form_type":"4"}},{"id":908907,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":24377,"kind":"person","name":"McMahon Robert W.","position":1,"cik":"0001608730","reported_name":"McMahon Robert W.","relationship":{"officer":true,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-13T02:37:44.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1250.034,"price":246.16,"value":307708.36944,"ownership":{"direct":true},"balance_after":2980.491,"source":{"system":"sec-edgar","filing":"0000105770-26-000007","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000007/form4.xml","form_type":"4"}},{"id":908906,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":24377,"kind":"person","name":"McMahon Robert W.","position":1,"cik":"0001608730","reported_name":"McMahon Robert W.","relationship":{"officer":true,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-13T02:37:44.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":true,"shares":4230.525,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":4230.525,"source":{"system":"sec-edgar","filing":"0000105770-26-000007","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000007/form4.xml","form_type":"4"}},{"id":954268,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":34322,"kind":"person","name":"HAUGEN JANET BRUTSCHEA","position":1,"cik":"0001185136","reported_name":"HAUGEN JANET BRUTSCHEA","relationship":{"director":true}}],"security":"Phantom Stock Unit","published_at":"2026-01-05T17:37:29.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":46,"price":275.14,"value":12656.44,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Awards of Phantom stock units are to be settled by delivery of shares of stock upon the reporting person's termination as a director."}],"balance_after":208.3,"derivative":{"underlying":"Common Stock","underlying_shares":46},"source":{"system":"sec-edgar","filing":"0000105770-26-000002","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000002/form4.xml","form_type":"4"}},{"id":975337,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":63769,"kind":"person","name":"Finch Norman D. Jr.","position":1,"cik":"0001577064","reported_name":"Finch Norman D. Jr.","relationship":{"officer":true,"officer_title":"SVP, GC & Corporate Secretary"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-10T15:33:41.000Z","date":"2025-12-08","kind":"grant","planned":false,"acquired":true,"shares":459,"price":269.08,"value":123507.72,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in four equal installments beginning on December 8, 2026."}],"balance_after":459,"derivative":{"exercise_price":269.08,"exercise_date":"2026-12-08","expiration_date":"2035-12-08","underlying":"Common Stock","underlying_shares":459},"source":{"system":"sec-edgar","filing":"0000105770-25-000100","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577025000100/form4.xml","form_type":"4"}}],"next_cursor":"2025-12-10T15:33:41.000000Z,975337"}